Neogen/$NEOG
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Neogen
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.
Ticker
$NEOG
Sector
Health
Primary listing
Employees
2,974
Headquarters
Website
Neogen Metrics
BasicAdvanced
$1.1B
-
-$5.03
1.79
-
Price and volume
Market cap
$1.1B
Beta
1.79
52-week high
$17.62
52-week low
$3.87
Average daily volume
6.1M
Financial strength
Current ratio
3.316
Quick ratio
1.623
Long term debt to equity
42.236
Total debt to equity
44.141
Interest coverage (TTM)
0.01%
Profitability
EBITDA (TTM)
117.807
Gross margin (TTM)
47.10%
Net profit margin (TTM)
-122.06%
Operating margin (TTM)
0.04%
Effective tax rate (TTM)
3.62%
Revenue per employee (TTM)
$300,000
Management effectiveness
Return on assets (TTM)
-0.03%
Return on equity (TTM)
-41.88%
Valuation
Price to revenue (TTM)
1.212
Price to book
0.52
Price to tangible book (TTM)
-2.69
Price to free cash flow (TTM)
-23.397
Free cash flow yield (TTM)
-4.27%
Free cash flow per share (TTM)
-0.214
Growth
Revenue change (TTM)
-3.20%
Earnings per share change (TTM)
11,469.70%
3-year revenue growth (CAGR)
19.28%
10-year revenue growth (CAGR)
12.20%
3-year earnings per share growth (CAGR)
123.89%
10-year earnings per share growth (CAGR)
31.03%
What the Analysts think about Neogen
Analyst ratings (Buy, Hold, Sell) for Neogen stock.
Bulls say / Bears say
Neogen's integration of the former 3M Food Safety Division is progressing well, with significant milestones achieved, such as the near-completion of the first Petrifilm production line, positioning the company for enhanced operational efficiency and product offerings. (marketscreener.com)
The Food Safety segment demonstrated resilience with a 7% core revenue growth outside the sample collection product line, indicating strong underlying demand for Neogen's products. (marketscreener.com)
Neogen's strategic focus on innovation and product development, including the introduction of new products in the fourth quarter, positions the company to capitalize on growth opportunities in the food and animal safety markets. (nasdaq.com)
Neogen reported a net loss of $11.0 million in Q3 2025, with a 3.4% decline in revenue to $221.0 million, reflecting operational challenges and market pressures. (marketscreener.com)
The company faced a significant net loss of $456.3 million in Q2 2025, primarily due to a non-cash goodwill impairment charge related to the acquisition of the former 3M Food Safety Division, raising concerns about the financial impact of recent acquisitions. (biospace.com)
Neogen's gross margin declined to 49.9% in Q3 2025 from 51.1% in the prior year, indicating increased costs and potential pricing pressures in its markets. (marketscreener.com)
Data summarised monthly by Lightyear AI. Last updated on 10 Jul 2025.
Neogen Financial Performance
Revenues and expenses
Neogen Earnings Performance
Company profitability
Neogen News
AllArticlesVideos
Deadline Alert: Neogen Corporation (NEOG) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
Business Wire·1 week ago
Neogen Announces Fourth-Quarter 2025 Results
Business Wire·1 week ago
Law Offices of Frank R. Cruz Encourages Neogen Corporation (NEOG) Investors to Inquire About Securities Fraud Class Action
Business Wire·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Neogen stock?
Neogen (NEOG) has a market cap of $1.1B as of August 08, 2025.
What is the P/E ratio for Neogen stock?
The price to earnings (P/E) ratio for Neogen (NEOG) stock is 0 as of August 08, 2025.
Does Neogen stock pay dividends?
No, Neogen (NEOG) stock does not pay dividends to its shareholders as of August 08, 2025.
When is the next Neogen dividend payment date?
Neogen (NEOG) stock does not pay dividends to its shareholders.
What is the beta indicator for Neogen?
Neogen (NEOG) has a beta rating of 1.79. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.